Survival After Extracorporeal Membrane Oxygenation Bridge to Lung Retransplantation.

ABSTRACT:

Background

Extracorporeal membrane oxygenation (ECMO) is increasingly used as a bridge to lung transplantation. Despite success in select populations, candidates requiring ECMO bridge to retransplantation have historically had poor 1-year survival. This study aimed to examine the characteristics of the recipient, donor, and transplant procedure type to guide selection of candidates for ECMO bridge to retransplantation.

Methods

This was a retrospective cohort study of all US adult lung retransplant recipients between May 5, 2005, and December 31, 2022. We evaluated 1-year survival of ECMO-bridged retransplant patients, stratified by time from initial transplant, procedure type (single or bilateral retransplant), and ECMO era (2005-2017 vs 2018-2022).

Results

In this na

SUBMITTER: Keen JL 

PROVIDER: S-EPMC11910802 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature